Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.35 - $3.28 $3.58 Million - $33.6 Million
-10,235,488 Reduced 99.06%
97,375 $34,000
Q1 2023

May 12, 2023

BUY
$3.28 - $4.81 $1.54 Million - $2.25 Million
468,584 Added 4.75%
10,332,863 $35.8 Million
Q4 2022

Feb 13, 2023

BUY
$3.65 - $4.82 $2.7 Million - $3.56 Million
738,474 Added 8.09%
9,864,279 $44.2 Million
Q3 2022

Nov 15, 2022

BUY
$2.66 - $3.97 $578,738 - $863,756
217,571 Added 2.44%
9,125,805 $33.2 Million
Q2 2022

Aug 15, 2022

BUY
$2.42 - $4.05 $11.5 Million - $19.3 Million
4,759,226 Added 114.71%
8,908,234 $23.6 Million
Q1 2022

May 13, 2022

BUY
$3.45 - $5.83 $14.3 Million - $24.2 Million
4,149,008 New
4,149,008 $16.3 Million

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.